Search research articles
Contact Us
Filters
Showing results (21-30 of 86) with videos related to
Page
of 9
Sort By:
Indian Journal of Thoracic and Cardiovascular Surgery
|
October 26, 2020
Evaluation of spinal cord protective threshold of serum memantine, an NMDA receptor antagonist, in a rabbit model of paraplegia
Nirmal Panthee, Minoru Ono, Takehito Yamamoto, et al.
The Journal of Antimicrobial Chemotherapy
|
March 15, 2023
Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia: a propensity score-adjusted non-inferior comparative study
Ryo Yamaguchi, Takehito Yamamoto, Koh Okamoto, et al.
Journal of Pharmaceutical Health Care and Sciences
|
December 9, 2020
Prediction of the permeability of antineoplastic agents through nitrile medical gloves by zone classification based on their physicochemical properties
Toyohito Oriyama, Takehito Yamamoto, Katsuhiko Nara, et al.
BMC Cancer
|
October 13, 2023
Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study
Katsuhiko Nara, Takehito Yamamoto, Hiroharu Yamashita, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
December 9, 2022
Impact of targeted intervention using a collaborative approach for oral third-generation cephalosporins: An interrupted time-series analysis
Ryo Yamaguchi, Koh Okamoto, Takehito Yamamoto, et al.
Journal of Pharmaceutical Health Care and Sciences
|
May 5, 2017
Evaluation of the permeation of antineoplastic agents through medical gloves of varying materials and thickness and with varying surface treatments
Toyohito Oriyama, Takehito Yamamoto, Yoshitsugu Yanagihara, et al.
International Journal of Clinical Oncology
|
February 6, 2019
Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns
Takehito Yamamoto, Kenji Kawada, Koya Hida, et al.
Science Translational Medicine
|
February 20, 2015
NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy
Tappei Takada, Yoshihide Yamanashi, Kentaro Konishi, et al.
Journal for Immunotherapy of Cancer
|
March 8, 2024
Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis
Katsuhiko Nara, Satoru Taguchi, Sebastiano Buti, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 19, 2005
Effects of the CYP3A5 genetic polymorphism on the pharmacokinetics of diltiazem
Takehito Yamamoto, Takahiro Kubota, Takeshi Ozeki, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 86) with videos related to
Sort By:
Page
of 9
Indian Journal of Thoracic and Cardiovascular Surgery
|
October 26, 2020
Evaluation of spinal cord protective threshold of serum memantine, an NMDA receptor antagonist, in a rabbit model of paraplegia
Nirmal Panthee, Minoru Ono, Takehito Yamamoto, et al.
The Journal of Antimicrobial Chemotherapy
|
March 15, 2023
Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia: a propensity score-adjusted non-inferior comparative study
Ryo Yamaguchi, Takehito Yamamoto, Koh Okamoto, et al.
Journal of Pharmaceutical Health Care and Sciences
|
December 9, 2020
Prediction of the permeability of antineoplastic agents through nitrile medical gloves by zone classification based on their physicochemical properties
Toyohito Oriyama, Takehito Yamamoto, Katsuhiko Nara, et al.
BMC Cancer
|
October 13, 2023
Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study
Katsuhiko Nara, Takehito Yamamoto, Hiroharu Yamashita, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
December 9, 2022
Impact of targeted intervention using a collaborative approach for oral third-generation cephalosporins: An interrupted time-series analysis
Ryo Yamaguchi, Koh Okamoto, Takehito Yamamoto, et al.
Journal of Pharmaceutical Health Care and Sciences
|
May 5, 2017
Evaluation of the permeation of antineoplastic agents through medical gloves of varying materials and thickness and with varying surface treatments
Toyohito Oriyama, Takehito Yamamoto, Yoshitsugu Yanagihara, et al.
International Journal of Clinical Oncology
|
February 6, 2019
Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns
Takehito Yamamoto, Kenji Kawada, Koya Hida, et al.
Science Translational Medicine
|
February 20, 2015
NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy
Tappei Takada, Yoshihide Yamanashi, Kentaro Konishi, et al.
Journal for Immunotherapy of Cancer
|
March 8, 2024
Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis
Katsuhiko Nara, Satoru Taguchi, Sebastiano Buti, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 19, 2005
Effects of the CYP3A5 genetic polymorphism on the pharmacokinetics of diltiazem
Takehito Yamamoto, Takahiro Kubota, Takeshi Ozeki, et al.
Page
of 9